Gliomas are the most common type of brain tumor that occur in adults and children.
Glioblastoma multiforme (GBM) is the most common, aggressive form of brain cancer in …

Glioblastoma (GB), an aggressive primary tumor of the central nervous system, represents
about 60% of all adult primary brain tumors. It is notorious for its extremely low (~ 5%) 5-year …

As a new cell-free therapy, exosomes have provided new ideas for the treatment of various
diseases. Human induced pluripotent stem cells (hiPSCs) cannot be used in clinical trials …

Glioblastoma multiforme (GBM) is the most common malignant brain tumor in adults and
despite recent advances in treatment modalities, GBM remains incurable. Injectable …

Neural stem cell (NSC) therapies are developing rapidly and have been proposed as a
treatment option for various neurological diseases, such as stroke, Parkinson's disease and …

A systematic investigation of stem cell-derived neural interfaces can facilitate the discovery
of the molecular mechanisms behind cell behavior in neurological disorders and accelerate …

Genetically engineered neural stem cells (NSCs) are a promising therapy for the highly
aggressive brain cancer glioblastoma (GBM); however, treatment durability remains a major …

Despite the recent influx of immunotherapies and small molecule drugs to treat tumors,
cancer remains a leading cause of death in the United States, in large part due to the …

Glioblastoma (GBM) is a malignant cancer that is fatal even after standard therapy and the
effects of current available therapeutics are not promising due its complex and evolving …

Converting human fibroblasts into personalized induced neural stem cells (hiNSC) that
actively seek out tumors and deliver cytotoxic agents is a promising approach for treating …